Rimonci Capital
Rimonci Capital is a venture capital firm established in 2016 and based in Beijing, China. The company specializes in cross-border investments between China and Israel, with a particular emphasis on the medical technology and healthcare sectors. Rimonci Capital targets opportunities in vision science, specifically in ophthalmology and optometry, aiming to foster innovation and growth in these fields. Through its strategic investments, the firm seeks to bridge the gap between Chinese and Israeli markets, facilitating the exchange of ideas and technologies in the healthcare domain.
Past deals in Lyon
Laclarée
Seed Round in 2025
Laclarée is a French company based in Lyon, founded in 2016, that specializes in developing adaptive eyeglasses specifically designed to correct presbyopia. The company's innovative product incorporates patented fluid technology, allowing the eyeglasses to automatically adjust to different viewing distances in real-time. This advancement aims to address the needs of individuals aged 45 and older who are often dissatisfied with traditional vision correction solutions, such as progressive lenses or the use of multiple pairs of glasses. By combining adaptive lens technology with refractive correction capabilities for conditions like astigmatism, myopia, and hyperopia, Laclarée seeks to provide a more effective solution for clear vision across various distances.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.